Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Sio Gene Therapies (SIOX) stock

Learn how to easily invest in Sio Gene Therapies stock.

Sio Gene Therapies Inc
NASDAQ: SIOX - USD
BIOTECHNOLOGY
$2.35
+$0.06 (+2.62%)

Sio Gene Therapies Inc is a biotechnology business based in the US. Sio Gene Therapies shares (SIOX) are listed on the NASDAQ and all prices are listed in US Dollars. Sio Gene Therapies employs 42 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Sio Gene Therapies

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SIOX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Sio Gene Therapies stock price (NASDAQ: SIOX)

Use our graph to track the performance of SIOX stocks over time.

Sio Gene Therapies shares at a glance

Information last updated 2021-07-24.
Latest market close$2.28
52-week range$1.87 - $5.74
50-day moving average $2.52
200-day moving average $2.63
Wall St. target price$8.42
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy Sio Gene Therapies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Sio Gene Therapies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Sio Gene Therapies price performance over time

Historical closes compared with the close of $2.28 from 2021-05-28

1 week (2021-07-13) N/A
1 month (2021-06-24) -12.98%
3 months (2021-04-20) N/A
6 months (2021-01-20) N/A
1 year (2020-07-20) N/A
2 years (2019-07-20) N/A
3 years (2018-07-20) N/A
5 years (2016-07-20) N/A

Sio Gene Therapies financials

Gross profit TTM $0
Return on assets TTM -23.05%
Return on equity TTM -35.07%
Profit margin 0%
Book value $1.78
Market capitalisation $163.5 million

TTM: trailing 12 months

Shorting Sio Gene Therapies shares

There are currently 1.3 million Sio Gene Therapies shares held short by investors – that's known as Sio Gene Therapies's "short interest". This figure is 2% down from 1.3 million last month.

There are a few different ways that this level of interest in shorting Sio Gene Therapies shares can be evaluated.

Sio Gene Therapies's "short interest ratio" (SIR)

Sio Gene Therapies's "short interest ratio" (SIR) is the quantity of Sio Gene Therapies shares currently shorted divided by the average quantity of Sio Gene Therapies shares traded daily (recently around 915503.5971223). Sio Gene Therapies's SIR currently stands at 1.39. In other words for every 100,000 Sio Gene Therapies shares traded daily on the market, roughly 1390 shares are currently held short.

However Sio Gene Therapies's short interest can also be evaluated against the total number of Sio Gene Therapies shares, or, against the total number of tradable Sio Gene Therapies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Sio Gene Therapies's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Sio Gene Therapies shares in existence, roughly 20 shares are currently held short) or 0.0281% of the tradable shares (for every 100,000 tradable Sio Gene Therapies shares, roughly 28 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Sio Gene Therapies.

Find out more about how you can short Sio Gene Therapies stock.

Sio Gene Therapies share dividends

We're not expecting Sio Gene Therapies to pay a dividend over the next 12 months.

Sio Gene Therapies share price volatility

Over the last 12 months, Sio Gene Therapies's shares have ranged in value from as little as $1.87 up to $5.74. A popular way to gauge a stock's volatility is its "beta".

SIOX.US volatility(beta: 1.77)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sio Gene Therapies's is 1.7666. This would suggest that Sio Gene Therapies's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Sio Gene Therapies overview

Sio Gene Therapies, Inc. , a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. The company develops AXO-Lenti-PD, in vivo lentiviral gene therapy, which is in Phase II clinical trials for the treatment of Parkinson's disease; AXO-AAV-GM1, an investigational gene therapy , which is in Phase I/II clinical trials for the treatment of GM1 gangliosidosis; and AXO-AAV-GM2, an investigational gene therapy, which is in Phase I/II clinical trials for the treatment of GM2 gangliosidosis. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc.

Stocks similar to Sio Gene Therapies

Frequently asked questions

What percentage of Sio Gene Therapies is owned by insiders or institutions?
Currently 27.101% of Sio Gene Therapies shares are held by insiders and 30.424% by institutions.
How many people work for Sio Gene Therapies?
Latest data suggests 42 work at Sio Gene Therapies.
When does the fiscal year end for Sio Gene Therapies?
Sio Gene Therapies's fiscal year ends in March.
Where is Sio Gene Therapies based?
Sio Gene Therapies's address is: 130 West 42nd Street, New York, NY, United States, 10036

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site